Related Experiment Videos
Treatment for refractory myasthenia gravis
T Sakano1, T Hamasaki, Y Kinoshita
1Department of Paediatrics, Hiroshima University School of Medicine, Japan.
Archives of Disease in Childhood
|August 1, 1989
Summary
High-dose intravenous methylprednisolone effectively treated ocular myasthenia gravis recurrence in a pediatric patient. This treatment led to sustained remission, allowing discontinuation of oral steroids.
Area of Science:
- Pediatric Neurology
- Immunology
- Ophthalmology
Background:
- Ocular myasthenia gravis (OMG) is a neuromuscular disorder affecting eye muscles.
- Treatment options for OMG include immunosuppressants and immunomodulators.
- Recurrence of symptoms can occur, necessitating treatment adjustments.